NCT00004996

Brief Summary

This study will compare the structure, chemical composition and other characteristics of skin and blood in people with and without parasitic infections. Cell samples will be taken from blisters produced by suction blistering. This study may provide new information about the interactions between parasites and the immune system that could lead to better treatments for these infections. Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18 years older may be eligible for this study. Following a medical history and physical exam, participants will undergo suction blistering to provide cells needed for study. A suction blister device is attached to the skin of the thigh. A heating element in the device heats the skin to speed blister formation. (This will feel only a slightly warm.) The device is removed after about two hours, when the blisters have formed. The blister tops are removed with sterile scissors. The blistered areas are then treated with special dressings to promote healing and the participant is discharged with further wound care instructions. A small amount of blood (around four tablespoons) may be drawn to compare chemicals in the blood with chemicals in the blister fluid. Participants will be contacted by telephone over the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and 1 year. Up to 60 blisters may be produced over a one-year period (in three separate sessions every six months) with no more than 20 raised per session....

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2000

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 23, 2000

Completed
15.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2015

Completed
Last Updated

December 12, 2019

Status Verified

April 22, 2015

First QC Date

March 22, 2000

Last Update Submit

December 11, 2019

Conditions

Keywords

Antigen PresentationCytokinesHelminthHealthy VolunteerCross-Over StudyHelminth Infection

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 18 and 65 years inclusive
  • Access to a primary medical care provider outside of the NIH
  • Able to give informed consent
  • Willingness to have history and physical examination annually

You may not qualify if:

  • History of malignancy or autoimmune disease such as rheumatoid arthritis, vasculitis, pyoderma gangrenosum
  • Use of systemic corticosteroids within the past month
  • Use of local corticosteroids at the proposed blistering site within the past month
  • Evidence of current acute infection
  • Personal or family history of keloid formation
  • Use of any investigative drugs within the past month
  • History of skin disease within the past one year (e.g. psoriasis, atopic dermatitis)
  • History of diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol. 1968 Feb;50(2):129-37. doi: 10.1038/jid.1968.15. No abstract available.

    PMID: 4868034BACKGROUND
  • Blauvelt A, Katz SI, Udey MC. Human Langerhans cells express E-cadherin. J Invest Dermatol. 1995 Feb;104(2):293-6. doi: 10.1111/1523-1747.ep12612830.

    PMID: 7829887BACKGROUND
  • Dale DC, Wolff SM. Skin window studies of the acute inflammatory responses of neutropenic patients. Blood. 1971 Aug;38(2):138-42. No abstract available.

    PMID: 4933314BACKGROUND

MeSH Terms

Conditions

HelminthiasisTrematode Infections

Condition Hierarchy (Ancestors)

Parasitic DiseasesInfections

Study Officials

  • Thomas B Nutman, M.D.

    National Institute of Allergy and Infectious Diseases (NIAID)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2000

First Posted

March 23, 2000

Study Start

March 20, 2000

Study Completion

April 22, 2015

Last Updated

December 12, 2019

Record last verified: 2015-04-22

Locations